IRIS
GIANNONI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.096
AS - Asia 13.049
EU - Europa 11.899
SA - Sud America 2.826
AF - Africa 337
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 30
Totale 49.268
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.907
SG - Singapore 4.749
RU - Federazione Russa 3.453
CN - Cina 3.146
IT - Italia 2.804
BR - Brasile 2.211
VN - Vietnam 1.812
GB - Regno Unito 1.764
BD - Bangladesh 947
HK - Hong Kong 920
DE - Germania 843
CA - Canada 832
UA - Ucraina 627
FR - Francia 439
SE - Svezia 436
IN - India 275
FI - Finlandia 273
DK - Danimarca 271
NL - Olanda 226
AR - Argentina 225
MX - Messico 220
IE - Irlanda 190
PL - Polonia 179
IL - Israele 177
TR - Turchia 160
ID - Indonesia 138
EC - Ecuador 127
ES - Italia 114
JP - Giappone 113
PK - Pakistan 111
IQ - Iraq 108
ZA - Sudafrica 107
AT - Austria 70
CO - Colombia 62
MA - Marocco 62
UZ - Uzbekistan 60
VE - Venezuela 56
AE - Emirati Arabi Uniti 43
CL - Cile 42
LT - Lituania 41
PH - Filippine 36
MY - Malesia 33
PY - Paraguay 33
SA - Arabia Saudita 32
KE - Kenya 31
EG - Egitto 28
TN - Tunisia 28
EU - Europa 27
NP - Nepal 25
PE - Perù 25
UY - Uruguay 23
HN - Honduras 22
CH - Svizzera 21
RO - Romania 21
JM - Giamaica 19
BE - Belgio 18
CR - Costa Rica 18
DZ - Algeria 18
AU - Australia 17
JO - Giordania 17
AZ - Azerbaigian 16
TH - Thailandia 15
BO - Bolivia 13
KG - Kirghizistan 13
KR - Corea 13
DO - Repubblica Dominicana 12
GR - Grecia 12
PS - Palestinian Territory 12
PT - Portogallo 12
NI - Nicaragua 11
CZ - Repubblica Ceca 10
SV - El Salvador 10
TT - Trinidad e Tobago 10
GT - Guatemala 9
NZ - Nuova Zelanda 9
PA - Panama 8
TW - Taiwan 8
BG - Bulgaria 7
ET - Etiopia 7
HU - Ungheria 7
KZ - Kazakistan 7
LY - Libia 7
OM - Oman 7
SI - Slovenia 7
AO - Angola 6
BH - Bahrain 6
CI - Costa d'Avorio 6
GE - Georgia 6
IR - Iran 6
MG - Madagascar 6
QA - Qatar 6
AL - Albania 5
CG - Congo 5
GY - Guiana 5
HR - Croazia 5
MD - Moldavia 5
MT - Malta 5
NO - Norvegia 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
Totale 49.161
Salva come PNG Salva come JPEG
Città #
Dallas 3.742
Singapore 2.379
Ashburn 1.540
San Jose 1.361
Beijing 1.244
Southend 907
Hong Kong 801
Chandler 734
Los Angeles 641
Moscow 597
Fairfield 585
Houston 549
Ho Chi Minh City 540
Woodbridge 469
Chicago 447
San Mateo 436
New York 429
Milan 426
Ann Arbor 422
Falls Church 406
Seattle 369
Hanoi 365
Cambridge 333
Jacksonville 333
Wilmington 324
The Dalles 310
Rome 289
Santa Clara 280
Council Bluffs 267
Ottawa 257
Buffalo 248
São Paulo 237
Boardman 229
Lauterbourg 224
Hefei 216
Dearborn 214
Dublin 188
Pisa 183
Salt Lake City 178
Portsmouth 170
Stevenage 164
Beauharnois 163
Orem 156
Tel Aviv 154
Warsaw 154
Munich 149
Dong Ket 147
Helsinki 142
London 140
Lawrence 132
Montreal 130
Brooklyn 121
Mexico City 113
Atlanta 100
Denver 100
Tokyo 99
Stockholm 92
Frankfurt am Main 90
Poplar 87
Chennai 85
Tampa 84
Toronto 83
Florence 80
Istanbul 77
Amsterdam 75
Johannesburg 73
Da Nang 72
Elk Grove Village 72
Montréal 72
Rio de Janeiro 71
Phoenix 69
Figino 67
Nuremberg 66
San Diego 64
Haiphong 62
Boston 57
Tashkent 55
Fremont 53
San Francisco 52
Columbus 51
Guayaquil 49
Manchester 49
Turin 49
Ankara 47
Bologna 47
Naples 47
Biên Hòa 45
Turku 44
Genoa 43
Mumbai 43
Brasília 41
Lappeenranta 40
Redwood City 40
Belo Horizonte 39
Paris 37
Quito 37
Dongguan 36
Guangzhou 36
Baghdad 35
Curitiba 35
Totale 28.581
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.706
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 609
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 512
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 454
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 401
A simple echocardiographic score to rule out cardiac amyloidosis 390
A simple echocardiographic score to rule out cardiac amyloidosis 364
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 358
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 351
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 347
Central sleep apnea and cardiovascular disease state-of-the-art 344
[Central apneas and cardiovascular diseases] 339
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 338
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 333
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 331
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 330
Prediction of the chemoreflex gain by common clinical variables in heart failure 330
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 329
Treating chemoreflex in heart failure: modulation or demolition? 326
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 319
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 317
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 316
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 316
Etiology, clinical presentation, and management of left main coronary artery aneurysms 314
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 313
Adrenergic activation in heart failure: blockade or rebalance? 313
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 306
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 304
Eligibility for vericiguat in a real‐world, contemporary heart failure population 303
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 301
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 300
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 299
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 297
Screening the health status of people working in a university 294
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 293
Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential 289
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 288
How to take arms against central apneas in heart failure 285
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 285
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 282
Diaphragm function does not independently predict exercise intolerance in patients with precapillary pulmonary hypertension after adjustment for right ventricular function 280
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 280
Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure 276
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 272
Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction. 271
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 269
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 269
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 267
Contribution of the lung to the genesis of cheyne-stokes respiration in heart failure: Plant gain beyond chemoreflex gain and circulation time 265
Effects of nasal high flow on sympathovagal balance, sleep, and sleep-related breathing in patients with precapillary pulmonary hypertension 264
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 262
Models of BOLD Signal Change in Breath Hold Studies and CO2 Challenges: Methodological Issues and Interpretation 262
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 262
B-type natriuretic peptide secretion following scuba diving 261
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 261
Improved survival in limited scleroderma-related pulmonary artery hypertension 261
A Novel Homozygous Mutation of the Desmoplakin Gene With Biventricular Arrhythmogenic Cardiomyopathy 261
Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan 259
Valve disease in cardiac amyloidosis: an echocardiographic score 259
null 258
Unveiling a sudden unexplained death case by whole exome sequencing and bioinformatic analysis 258
null 258
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones 255
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 255
APAP therapy does not improve impaired sleep quality and sympatho-vagal balance: a randomized trial in patients with obstructive sleep apnea and systolic heart failure 254
Correlational analysis of electroencephalographic and end-tidal carbon dioxide signals during breath-hold exercise 254
null 253
A Novel Workflow for Electrophysiology Studies in Patients with Brugada Syndrome 252
Prognostic value of right ventricular refractory period heterogeneity in Type-1 Brugada electrocardiographic pattern 250
Mapping dependencies of BOLD signal change to end-tidal CO2: Linear and nonlinear modeling, and effect of physiological noise correction 249
An atypical case of cardiac amyloidosis. 248
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 247
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register 246
In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation 244
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 243
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 243
Heart Failure Results in Inspiratory Muscle Dysfunction Irrespective of Left Ventricular Ejection Fraction 242
Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients. 240
High-risk NSTEMI due to subclavian artery atherothrombosis in a prior coronary artery bypass graft patient 239
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction 239
Renin profiling predicts neurohormonal response to sacubitril/valsartan 239
Chemoreflex and Baroreflex Sensitivity Hold a Strong Prognostic Value in Chronic Heart Failure 238
Effects of hyperventilation length on muscle sympathetic nerve activity in healthy humans simulating periodic breathing 238
Role of Imaging in Cardiomyopathies 237
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea 237
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? 237
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 236
Autonomic and respiratory consequences of altered chemoreflex function: clinical and therapeutic implications in cardiovascular diseases 235
Changes in chemoreflex characteristics following acetazolamide administration in patients with chronic heart failure and Cheyne Stokes respiration 235
Ld-EEG Effective Brain Connectivity in Patients With Cheyne-Stokes Respiration 234
A scoping review of machine learning models to predict risk of falls in elders, without using sensor data 233
Inspiratory muscle dysfunction and restrictive lung function impairment in congenital heart disease: Association with immune inflammatory response and exercise intolerance 230
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry 229
Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure. 229
Impact of Simulated Hyperventilation and Periodic Breathing on Sympatho-Vagal Balance and Hemodynamics in Patients with and without Heart Failure 229
On the Use of Linear-Modelling-based Algorithms for Physiological Noise Correction in fMRI Studies of the Central Breathing Control 228
null 228
Diagnosis of preclinical /mild heart failure with B-type natriuretic peptides: compariosn betwwen BNP and NT-proBNP immunoassay methods 227
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 226
Breathless heart: only when the neck is deep in water? 226
Totale 29.765
Salva come PNG Salva come JPEG
Categoria #
all - tutte 239.234
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 239.234
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.330 146 385 113 278 71 43 239 431 151 247 55 171
2022/20231.643 133 154 83 209 220 243 17 143 253 32 81 75
2023/20241.162 107 34 280 90 37 88 80 49 30 39 39 289
2024/202510.696 65 80 466 207 596 585 1.383 2.351 871 949 1.993 1.150
2025/202626.160 1.363 4.006 2.931 3.638 2.944 1.612 2.391 1.058 1.413 1.557 1.726 1.521
2026/2027601 601 0 0 0 0 0 0 0 0 0 0 0
Totale 49.539